Neomycin C (hexaacetate)

Neomycin C hexaacetate, a tetracyclic antibacterial agent, is a major active isomeric components of the Neomycin complex. Neomycin, is a 2-DOS-containing aminoglycoside, consisting of Neomycin A, Neomycin B, and Neomycin C[1][2].

Product Specifications

UNSPSC

12352005

Target

Bacterial

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Purity

97.10

Smiles

N[C@@H]1[C@@H](O[C@@H]2[C@H](N)[C@@H](O)[C@H](O)[C@@H](CN)O2)[C@H](O[C@H]3[C@H](O)[C@H](O[C@@H]4[C@H](N)[C@@H](O)[C@H](O)[C@@H](CN)O4)[C@@H](CO)O3)[C@@H](O)[C@H](N)C1.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O

Molecular Formula

C35H70N6O25

Molecular Weight

974.96

References & Citations

[1]Huang F, et al. Elaboration of neosamine rings in the biosynthesis of neomycin and butirosin. Chembiochem. 2007 Feb 12;8 (3) :283-8. |[2]Neomycin C. PubChem.